Cellectar Biosciences Stock Market Value
| CLRB Stock | USD 3.21 0.17 5.59% |
| Symbol | Cellectar |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. Projected growth potential of Cellectar fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cellectar Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Cellectar Biosciences requires distinguishing between market price and book value, where the latter reflects Cellectar's accounting equity. The concept of intrinsic value - what Cellectar Biosciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cellectar Biosciences' price substantially above or below its fundamental value.
It's important to distinguish between Cellectar Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellectar Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cellectar Biosciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cellectar Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectar Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectar Biosciences.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Cellectar Biosciences on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Cellectar Biosciences or generate 0.0% return on investment in Cellectar Biosciences over 90 days. Cellectar Biosciences is related to or competes with AEON Biopharma, Bolt Biotherapeutics, Cingulate, Sensei Biotherapeutics, Lyra Therapeutics, Imunon, and Marker Therapeutics. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercial... More
Cellectar Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectar Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectar Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.81 | |||
| Information Ratio | 0.0057 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (7.25) | |||
| Potential Upside | 7.8 |
Cellectar Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectar Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectar Biosciences' standard deviation. In reality, there are many statistical measures that can use Cellectar Biosciences historical prices to predict the future Cellectar Biosciences' volatility.| Risk Adjusted Performance | 0.0256 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | 0.0063 | |||
| Treynor Ratio | 0.0783 |
Cellectar Biosciences February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0256 | |||
| Market Risk Adjusted Performance | 0.0883 | |||
| Mean Deviation | 4.53 | |||
| Semi Deviation | 5.56 | |||
| Downside Deviation | 5.81 | |||
| Coefficient Of Variation | 4753.71 | |||
| Standard Deviation | 6.41 | |||
| Variance | 41.11 | |||
| Information Ratio | 0.0057 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | 0.0063 | |||
| Treynor Ratio | 0.0783 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (7.25) | |||
| Potential Upside | 7.8 | |||
| Downside Variance | 33.77 | |||
| Semi Variance | 30.89 | |||
| Expected Short fall | (5.47) | |||
| Skewness | 0.5486 | |||
| Kurtosis | 2.95 |
Cellectar Biosciences Backtested Returns
At this point, Cellectar Biosciences is slightly risky. Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of 0.0109, which signifies that the company had a 0.0109 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Cellectar Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Cellectar Biosciences' Downside Deviation of 5.81, mean deviation of 4.53, and Risk Adjusted Performance of 0.0256 to double-check if the risk estimate we provide is consistent with the expected return of 0.0728%. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cellectar Biosciences will likely underperform. Cellectar Biosciences right now shows a risk of 6.69%. Please confirm Cellectar Biosciences jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to decide if Cellectar Biosciences will be following its price patterns.
Auto-correlation | 0.58 |
Modest predictability
Cellectar Biosciences has modest predictability. Overlapping area represents the amount of predictability between Cellectar Biosciences time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectar Biosciences price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Cellectar Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cellectar Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cellectar Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cellectar Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cellectar Biosciences Stock:Check out Cellectar Biosciences Correlation, Cellectar Biosciences Volatility and Cellectar Biosciences Performance module to complement your research on Cellectar Biosciences. For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.